This is an observational prospective cohort study to evaluate the clinical course and outcomes of COVID-19 and the underlying disease in patients with hematologic disease (malignant or non-malignant).
This is a web-based registry. After registration, physicians from hematology clinical centers
and hospitals in Russia will receive access to the web platform for clinical trial management
to fill in the online data collection form in a de-identified manner. This form includes
questions about general clinical history of hematologic disease, manifestation, treatment,
and the course of COVID-19, concomitant conditions, consequences on the hematologic disease,
short-term and long-term outcomes. It will take approximately 10 min to answer the questions.
Patients will be followed for 30 days after COVID-19 diagnosis and up to 6 months for
hematologic disease outcomes and overall survival assessment.
Other: Non-interventional study
Non-interventional study
Inclusion Criteria
- Age 18 or older
- Any previously or currently diagnosed hematologic disease
- Laboratory confirmed or suspected (based on clinical symptoms and/or CT) COVID-19
- Known outcome of COVID-19 in case of retrospective data input (protocol allows
retrospective data input for patients who were prospectively followed in local
centers)
Exclusion Criteria
• Loss of follow-up within 30 days after COVID-19 diagnosis
Regional Clinical Hospital No1
Ekaterinburg, Russian Federation
Republican Clinical Hospital of Tatarstan
Kazan, Russian Federation
City Hospital n.a. V.V. Veresaev
Moscow, Russian Federation
Clinical Hospital n.a. S.P. Botkin
Moscow, Russian Federation
N.V. Sklifosovsky Emergency Institute
Moscow, Russian Federation
National Research Center for Hematology
Moscow, Russian Federation
Regional Clinical Hospital N.A. Semashko
Nizhny Novgorod, Russian Federation
Regional Hospital
Novosibirsk, Russian Federation
Regional Clinical Hospital
Omsk, Russian Federation
RM Gorbacheva Research Institute of Pediatric Oncology, Hematology and Transplantation, Pavlov University
Saint Petersburg, Russian Federation
Republican Clinical Hospital No4
Saransk, Russian Federation
Republic Clinical Hospital n.a. N.A. Semashko
Ulan-Ude, Russian Federation
Regional Clinical Hospital
Vladimir, Russian Federation
Regional Clinical Hospital No2
Vladivostok, Russian Federation
Regional Clinical Hospital
Yaroslavl, Russian Federation
Elena Parovichnikova, Study Chair
National Research Center for Hematology